Recent Press Releases

Ventana Medical Systems, Inc., Convenes International Patient Safety Advisory Board To Advance Standard Of Care And Reduce Risk Of Misdiagnosis

TUCSON, Ariz., Feb. 25, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.

NICE recommendation set to leave patients with newly diagnosed advanced melanoma without access to Yervoy® (ipilimumab)

NICE recommendation set to leave patients with newly diagnosed advanced melanoma without access to Yervoy® (ipilimumab) - Draft guidance effectively denies access to ipilimumab for NHS patients...

Almac adds simple solutions to bridge the gap between clinical and commercial packaging

Almac adds simple solutions to bridge the gap between clinical and commercial packaging Addressing client demand to ease the transition between clinical and commercial launch for blister...

Moody's: AbbVie, Amgen and Roche most exposed to biosimilar drugs market

Moody's: AbbVie, Amgen and Roche most exposed to biosimilar drugs market Global Credit Research - 25 Feb 2014 New York, February 25, 2014 -- Companies are racing to expand the global biosimilar...

NICE consults on draft guidance recommending new drug for type 2 diabetes

NICE consults on draft guidance recommending new drug for type 2 diabetes NICE, the health and social care guidance body, is currently appraising canagliflozin (Invokana, Janssen-Cilag) when used in...

Novartis shareholders approve all resolutions proposed by Novartis Board of Directors

Novartis shareholders approve all resolutions proposed by Novartis Board of Directors - Shareholders approve 17th consecutive dividend increase to CHF 2.45 (+7%) per share for 2013, representing a...

Public Citizen Petitions FDA for a Black Box Warning on Testosterone Products

Public Citizen Petitions FDA for a Black Box Warning on Testosterone Products More Than 5 Million Prescriptions Were Filled Last Year; Products Are Associated With Heart Attacks and Other...

Iroko Pharmaceuticals Receives FDA Approval for TIVORBEX™

Iroko Pharmaceuticals Receives FDA Approval for TIVORBEX™ New Lower Dose NSAID Marks Iroko's Second FDA Approval in Approximately Four Months PHILADELPHIA, FEBRUARY 24, 2014 — Iroko...

Elanco Announces Agreement to Acquire Lohmann Animal Health

Deal Provides Elanco with a Leading Poultry Vaccine Portfolio and Manufacturing Capabilities

GREENFIELD, IN,

Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses

Endo Pharmaceuticals and Endo Health Solutions to Pay $192.7 Million to Resolve Criminal and Civil Liability Relating to Marketing of Prescription Drug Lidoderm for Unapproved Uses Pharmaceutical...

Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13* Data to Be Presented at 9th International...

U.S. Food and Drug Administration Approves KALYDECO™ (ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis

U.S. Food and Drug Administration Approves KALYDECO™ (ivacaftor) for Use in Eight Additional Mutations that Cause Cystic Fibrosis -KALYDECO is the first medicine to treat the underlying cause...

ThromboGenics' Board Announces Decision to Explore Strategic Options for the Company

ThromboGenics' Board Announces Decision to Explore Strategic Options for the Company 24 Feb 2014 Regulated Information Focus on Realizing the Commercial Potential of JETREA® in the US and...

Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13*

Pfizer Announces Positive Top-Line Results Of Landmark Community-Acquired Pneumonia Immunization Trial In Adults (CAPiTA) Evaluating Efficacy Of Prevenar 13* Data to Be Presented at 9th International...

Innovus Pharma Announces Availability of EjectDelay(TM) for Premature Ejaculation in the United States

Innovus Pharma Announces Availability of EjectDelay(TM) for Premature Ejaculation in the United States SAN DIEGO, Feb 21, 2014 (GLOBE NEWSWIRE via COMTEX) -- Innovus Pharmaceuticals, Inc.,...

Abbott Declares 361st Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Feb.

Lilly to Participate in Cowen Healthcare Conference

INDIANAPOLIS, Feb.

Novartis shows continued commitment in Japan with Lucentis® approval in fourth Japanese indication, diabetic macular edema

Novartis shows continued commitment in Japan with Lucentis® approval in fourth Japanese indication, diabetic macular edema Lucentis is the first anti-VEGF therapy approved for diabetic macular...